Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030

Published by The Business Research Company Product code 1009551
Published Pre-Order Content info 175 Pages
Delivery time: 2-10 business days
Price
Back to Top
Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030
Published: Pre-Order Content info: 175 Pages
Description

Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030 from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for antivirals which play a critical role in the treatment of patients with Covid 19.

Antivirals help cure patients suffering from viral diseases including Covid-19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antivirals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antivirals global market report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider antivirals market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The antivirals market market section of the report gives context. It compares the antivirals market market with other segments of the antivirals market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, antivirals market indicators comparison.

Scope

Markets Covered: 1) By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Others

2) By Application: HIV; Hepatitis; Herpes; Influenza; Others

3) By Type: Branded; Generic

Companies Mentioned: AbbVie Inc.; Bristol-Myers-Squibb; Cipla; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Table of Contents

1. Executive Summary

2. Antivirals Market Characteristics

3. Antivirals Market Trends And Strategies

4. Impact Of COVID-19 On Antivirals

5. Antivirals Market Size And Growth

  • 5.1. Global Antivirals Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Antivirals Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Antivirals Market Segmentation

  • 6.1. Global Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • DNA Polymerase Inhibitors
  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • Neuraminidase Inhibitors
  • Others
  • 6.2. Global Antivirals Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • HIV
  • Hepatitis
  • Herpes
  • Influenza
  • Others
  • 6.3. Global Antivirals Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Branded
  • Generic

7. Antivirals Market Regional And Country Analysis

  • 7.1. Global Antivirals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Antivirals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Antivirals Market

  • 8.1. Asia-Pacific Antivirals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Antivirals Market

  • 9.1. China Antivirals Market Overview
  • 9.2. China Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Antivirals Market

  • 10.1. India Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Antivirals Market

  • 11.1. Japan Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Antivirals Market

  • 12.1. Australia Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Antivirals Market

  • 13.1. Indonesia Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Antivirals Market

  • 14.1. South Korea Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Antivirals Market

  • 15.1. Western Europe Antivirals Market Overview
  • 15.2. Western Europe Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Antivirals Market

  • 16.1. UK Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Antivirals Market

  • 17.1. Germany Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Antivirals Market

  • 18.3. France Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Antivirals Market

  • 19.1. Eastern Europe Antivirals Market Overview
  • 19.2. Eastern Europe Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Antivirals Market

  • 20.1. Russia Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Antivirals Market

  • 21.1. North America Antivirals Market Overview
  • 21.2. North America Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Antivirals Market

  • 22.1. USA Antivirals Market Overview
  • 22.2. USA Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Antivirals Market

  • 23.1. South America Antivirals Market Overview
  • 23.2. South America Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Antivirals Market

  • 24.1. Brazil Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Antivirals Market

  • 25.1. Middle East Antivirals Market Overview
  • 25.2. Middle East Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Antivirals Market

  • 26.1. Africa Antivirals Market Overview
  • 26.2. Africa Antivirals Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Antivirals Market Competitive Landscape And Company Profiles

  • 27.1. Antivirals Market Competitive Landscape
  • 27.2. Antivirals Market Company Profiles
    • 27.2.1. AbbVie Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Bristol-Myers-Squibb
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Cipla
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. F. Hoffmann-La Roche Ltd
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Gilead Sciences Inc
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Antivirals Pipeline Analysis

29. Key Mergers And Acquisitions In The Antivirals Market

30. Antivirals Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top